Geladaris, Anastasia
Torke, Sebastian
Weber, Martin S.
Funding for this research was provided by:
Georg-August-Universität Göttingen
Article History
Accepted: 21 August 2022
First Online: 30 September 2022
Change Date: 23 November 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. This paper was not funded. We acknowledge support by the Open Access Publication Funds of the Göttingen University.
: A.G. has nothing to disclose. S.T. has received travel support from EMD Serono and research support from the Universitätsmedizin Göttingen (Startförderung). M.S.W. receives research support from the National Multiple Sclerosis Society (NMSS; PP 1660), the Deutsche Forschungsgemeinschaft (DFG; WE 3547/5-1), from Novartis, TEVA, Biogen-Idec, Roche, Merck and the ProFutura Programm of the Universitätsmedizin Göttingen.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: AG, ST and MSW participated in the concept, writing, and review of this article.